EcoDrugPlus

Gonadotropin-Releasing Hormone Ii Receptor-Like

Ensembl ID : ENSSTUG00000031678
Gene Symbol: LOC115175783
3 Cross references
129 Possible Orthologues:

Gonadotropin-Releasing Hormone Ii Receptor-Like

Ensembl ID : ENSSTUG00000014608
Gene Symbol: LOC115179884
2 Cross references
148 Possible Orthologues:

Gonadotropin-Releasing Hormone Ii Receptor-Like

Ensembl ID : ENSSTUG00000046499
Gene Symbol: LOC115177142
2 Cross references
149 Possible Orthologues:

Granzyme-Like Protein 2

Ensembl ID : ENSSTUG00000044825
Gene Symbol: LOC115158213
2 Cross references
990 Possible Orthologues:

Growth Hormone Releasing Hormone Receptor

Ensembl ID : ENSSTUG00000008775
Gene Symbol: GHRHR
3 Cross references
187 Possible Orthologues:

Growth Hormone Secretagogue Receptor

Ensembl ID : ENSSTUG00000003719
Gene Symbol: GHSR
3 Cross references
207 Possible Orthologues:

Growth Hormone Secretagogue Receptor

Ensembl ID : ENSSTUG00000036385
Gene Symbol: GHSR
3 Cross references
208 Possible Orthologues:

Growth Hormone-Releasing Hormone Receptor-Like

Ensembl ID : ENSSTUG00000040130
Gene Symbol: LOC115151588
2 Cross references
186 Possible Orthologues:

Guanylate Cyclase 1 Soluble Subunit Alpha 2

Ensembl ID : ENSSTUG00000026317
Gene Symbol: GUCY1A2
3 Cross references
192 Possible Orthologues:

Guanylate Cyclase 1 Soluble Subunit Alpha 2

Ensembl ID : ENSSTUG00000011248
Gene Symbol: GUCY1A2
3 Cross references
197 Possible Orthologues:

Guanylate Cyclase Soluble Subunit Alpha-1-Like

Ensembl ID : ENSSTUG00000018547
Gene Symbol: LOC115192056
3 Cross references
195 Possible Orthologues:

Guanylate Cyclase Soluble Subunit Alpha-1-Like

Ensembl ID : ENSSTUG00000044656
Gene Symbol: LOC115202058
3 Cross references
195 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).